Back to Agenda
Session 8, Track C: From Self-Care to Surveillance: Emerging Tools for Detecting Safety Signals
Session Chair(s)
Mei Lam, BSN, RN
Associate Director Consumer Safety Regions Americas, Haleon, Canada
Nadia Latif, MS
Senior Manager, Pharmacovigilance, Ipsen Biopharmaceuticals Canada Inc., Canada
Discover how Health Canada manages safety signals for self-care products and the challenges of post-market surveillance. Learn how advanced technologies, including AI-enabled devices, are transforming safety monitoring. These tools help detect signals earlier across a range of product types. Explore how timely interventions driven by smart technologies can lead to better patient outcomes.
- Challenges in the Post-market Vigilance of Health Products Available for Self-selection
Jasmine Bhathena, Health Canada - Devices, Detection, and AI (oh my!)
Anand Sudhakar Tamilarasan, ATJP Consulting Services
Learning Objective :
At the conclusion of this session, participants should be able to:
- Describe the process used by Health Canada for safety signal management and identify key challenges in the post-market surveillance of non-prescription drugs and natural health products
- Understand how advanced technologies, including AI-enabled devices, are being integrated to proactively detect safety signals and enhance patient safety along with the associated challenges and risks
Speaker(s)
Jasmine Bhathena, PHD, MS, MSC
Senior Scientific Evaluator, BBRS, MHPD, Health Canada, Canada
Challenges in the Post-market Vigilance of Health Products Available for Self-selection
Anand Sudhakar Tamilarasan
VP, Digital Transformation Leader, ATJP Consulting Services, United States
Devices, Detection, and AI (oh my!)
Have an account?